MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
22 hedge funds and large institutions have $12M invested in MorphoSys AG American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.
4% less funds holding
Funds holding: 23 → 22 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
30% less capital invested
Capital invested by funds: $17.3M → $12M (-$5.26M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.79M |
| 2 |
Optiver Holding
Amsterdam,
Netherlands
|
+$388K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$223K |
| 4 |
Morgan Stanley
New York
|
+$90K |
| 5 |
ECM
Evergreen Capital Management
Bellevue,
Washington
|
+$72.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.16M |
| 2 |
Millennium Management
New York
|
-$618K |
| 3 |
BlackRock
New York
|
-$430K |
| 4 |
HF
HRT Financial
New York
|
-$308K |
| 5 |
HJIM
Henry James International Management
New York
|
-$271K |
MOR Hedge Fund Activity: Q2 2022 in Review
22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q2 2022, worth a combined $12M — down 30% from $17.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MOR and 7 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 6 added.
The largest buyer was Hudson Bay Capital Management, adding an estimated $1.79M. The largest seller was Candriam SCA, cutting an estimated $1.16M.
- 22 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q2 2022, down from 23 in Q1 2022.
- Funds reported $12M of MorphoSys AG American Depositary Shares stock for Q2 2022, down 30% quarter-over-quarter.
- 7 funds opened new MorphoSys AG American Depositary Shares positions in Q2 2022 and 8 closed out, a net change of -1 holder.
- The largest MorphoSys AG American Depositary Shares buyer in Q2 2022 was Hudson Bay Capital Management, an estimated $1.79M added.
- The largest MorphoSys AG American Depositary Shares seller in Q2 2022 was Candriam SCA, an estimated $1.16M sold.
Based on aggregated 13F filings for Q2 2022.